|
| | Irinotecan Hydroxyl Acid Basic information |
| Product Name: | Irinotecan Hydroxyl Acid | | Synonyms: | Irinotecan Hydroxyl Acid;Irinotecan IMpurity;Irinotecan Impurity 28;Indolizino[1,2-b]quinoline-7-acetic acid, α,12-diethyl-9,11-dihydro-α,2-dihydroxy-8-(hydroxymethyl)-9-oxo-, (αS)- | | CAS: | 142677-15-4 | | MF: | C22H22N2O6 | | MW: | 410.43 | | EINECS: | | | Product Categories: | | | Mol File: | 142677-15-4.mol |  |
| | Irinotecan Hydroxyl Acid Chemical Properties |
| Boiling point | 829.8±65.0 °C(Predicted) | | density | 1.54±0.1 g/cm3(Predicted) | | solubility | DMSO (Slightly, Heated), Methanol (Slightly, Sonicated), Water (Slightly) | | form | Solid | | pka | 2.88±0.10(Predicted) | | color | Light Yellow to Dark Yellow | | Stability: | Hygroscopic |
| | Irinotecan Hydroxyl Acid Usage And Synthesis |
| Uses | The active metabolite of Irinotecan (carboxylate form). SN-38 lactone and carboxylate may be considered pharmacokinetically distinct agents. |
| | Irinotecan Hydroxyl Acid Preparation Products And Raw materials |
|